One of the most emerging markets in Asia and Pacific Region is Korea. Eurocine Vaccines will participate in this important business place – celebrating it’s 12th anniversary – presenting the company, technology plattform Endocine™ and the first product candidate Immunose™ FLU. CEO Hans Arwidsson is also invited as one of the speakers. Date and time to be announced later.

More information can be found at: BIO Korea

Meetings with CEO Hans Arwidsson can be made through the Partnering System:BIO Korea Partnering